ACADIA Pharmaceuticals (ACAD)

Create an Alert
18.09 -0.34  -1.84%   NASDAQ Jun 19, 5:00PM BATS Real time Currency in USD

ACADIA Pharmaceuticals R&D Expense Quarterly:

4.43M for March 31, 2013
View Full Chart

ACADIA Pharmaceuticals R&D Expense Quarterly Chart

    ACADIA Pharmaceuticals Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 4.43M
    Dec. 31, 2012 4.901M
    Sept. 30, 2012 4.40M
    June 30, 2012 4.472M
    March 31, 2012 5.021M
    Dec. 31, 2011 4.424M
    Sept. 30, 2011 4.158M
    June 30, 2011 4.315M
    March 31, 2011 4.412M
    Dec. 31, 2010 4.757M
    Sept. 30, 2010 4.965M
    June 30, 2010 5.041M
    March 31, 2010 5.815M
    Dec. 31, 2009 7.836M
    Sept. 30, 2009 9.215M
    June 30, 2009 11.98M
    March 31, 2009 12.55M
    Dec. 31, 2008 12.15M
    Sept. 30, 2008 13.40M
    June 30, 2008 16.04M
    March 31, 2008 Go Pro
       
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    ACAD R&D Expense Quarterly Benchmarks

    Companies
    MannKind Corporation 26.40M
    Allergan 248.80M
    Insmed 10.33M

    ACAD R&D Expense Quarterly Rankings

    Overall 93rd percentile
    1114 of 16782
    Sector 77th percentile
    320 of 1410 in Healthcare
    Industry 68th percentile
    145 of 454 in Biotechnology

    ACAD R&D Expense Quarterly Range, Past 5 Years

    Minimum 4.158M Sep 2011
    Maximum 16.04M Jun 2008
    Average 7.214M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');